Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 14 2025
0mins
Source: Newsfilter
Merger Announcement: Vyome Therapeutics has completed its merger with ReShape Lifesciences, and the new entity will operate under the name Vyome Holdings, Inc. starting August 15, 2025, with the trading symbol "HIND."
Company Focus and Future Outlook: Vyome aims to leverage its clinical-stage assets to address immuno-inflammatory conditions while maintaining a cost-efficient operation across the US-India innovation corridor, although future performance is subject to uncertainties and risks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
